tiprankstipranks
Trending News
More News >
Pediatrix Medical Group (MD)
NYSE:MD
US Market
Advertisement

Pediatrix Medical Group (MD) Earnings Dates, Call Summary & Reports

Compare
241 Followers

Earnings Data

Report Date
Feb 19, 2026
Before Open (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
0.52
Last Year’s EPS
0.51
Same Quarter Last Year
Based on 4 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Sep 30, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call highlighted strong financial performance with exceeded expectations in adjusted EBITDA, robust year-to-date results, and strategic share buybacks. The company's innovative technology and research leadership were emphasized as key differentiators. However, a revenue decrease due to portfolio restructuring and increased G&A expenses were noted as challenges.
Company Guidance
During the third quarter of 2025, Pediatrix Medical Group, Inc. reported stronger-than-expected financial performance, surpassing expectations with an adjusted EBITDA of $87 million, driven by favorable pricing, collections, and expense controls. The company provided guidance for the full year's adjusted EBITDA in the range of $270 million to $290 million, reflecting variability due to practice bonus variability. Key performance indicators included a consolidated revenue decrease due to portfolio restructuring, offset by same-unit growth of 8%, pricing up by 7.5%, and patient service volumes increasing by just under 40 basis points. The company also highlighted a strong cash position with $340 million in cash and net debt of just over $260 million, and an operating cash flow of $138 million compared to $96 million in the prior year. Pediatrix Medical Group emphasized its commitment to research and technology through initiatives like BabySteps, contributing to its leadership in neonatology and partnership with hospital systems.
Exceeded EBITDA Expectations
Adjusted EBITDA of $87 million exceeded expectations, driven by positive outcomes in pricing, collections, and expense controls.
Strong Year-to-Date Performance
2025 year-to-date results have been strong with no expectation of deviations from normal seasonality in the fourth quarter.
Share Buyback Achievement
Pediatrix bought back 1.2 million shares during the quarter, with a total of 1.7 million shares bought back to date.
Strong Same-Unit Growth
Same-unit growth of 8% with pricing up 7.5% and patient service volumes up 40 basis points.
Increased Operating Cash Flow
Generated $138 million in operating cash flow, up from $96 million in the prior year.
Innovative Technology Implementation
Introduction of proprietary system BabySteps, enhancing clinical outcomes for NICU patients.
Research Leadership
Pediatrix's clinicians authored 1,395 peer-reviewed publications, with substantial clinical research activity.

Pediatrix Medical Group (MD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

MD Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 19, 2026
2025 (Q4)
0.52 / -
0.51
Sep 30, 2025
2025 (Q3)
0.47 / 0.67
0.4452.27% (+0.23)
Jun 30, 2025
2025 (Q2)
0.42 / 0.53
0.3455.88% (+0.19)
May 06, 2025
2025 (Q1)
0.24 / 0.33
0.265.00% (+0.13)
Feb 20, 2025
2024 (Q4)
0.37 / 0.51
0.3259.38% (+0.19)
Nov 01, 2024
2024 (Q3)
0.37 / 0.44
0.3237.50% (+0.12)
Aug 06, 2024
2024 (Q2)
0.31 / 0.34
0.39-12.82% (-0.05)
May 07, 2024
2024 (Q1)
0.18 / 0.20
0.23-13.04% (-0.03)
Feb 20, 2024
2023 (Q4)
0.33 / 0.32
0.47-31.91% (-0.15)
Nov 02, 2023
2023 (Q3)
0.43 / 0.32
0.4-20.00% (-0.08)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

MD Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Sep 30, 2025
$16.22$16.75+3.27%
Jun 30, 2025
$14.03$14.35+2.28%
May 06, 2025
$12.95$14.48+11.81%
Feb 20, 2025
$14.11$17.23+22.11%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Pediatrix Medical Group (MD) report earnings?
Pediatrix Medical Group (MD) is schdueled to report earning on Feb 19, 2026, Before Open (Confirmed).
    What is Pediatrix Medical Group (MD) earnings time?
    Pediatrix Medical Group (MD) earnings time is at Feb 19, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is MD EPS forecast?
          MD EPS forecast for the fiscal quarter 2025 (Q4) is 0.52.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis